UCLA Torrance Oncology — Torrance, California

UCLA Torrance Oncology is a clinical research site located in Torrance, California, United States 90505.

Crixeo Health Trust Score: 61/100 (FAIR). This profile has not yet been claimed by the site owner.

UCLA Torrance Oncology has participated in 3 clinical trials with 1 currently active.

Therapeutic areas: HER2-positive Breast Cancer, Advanced Solid Tumors, Cancer.

Sponsors: Seagen, a wholly owned subsidiary of Pfizer, Pfizer.

Sponsor Feasibility Report

Trust Score: 61/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for UCLA Torrance Oncology?

UCLA Torrance Oncology has a Crixeo Trust Score of 61/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has UCLA Torrance Oncology conducted?

UCLA Torrance Oncology has 3 clinical trials on record, with 1 currently active. Their work covers HER2-positive Breast Cancer, Advanced Solid Tumors, Cancer.

Is UCLA Torrance Oncology accredited by Crixeo Health?

UCLA Torrance Oncology has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about UCLA Torrance Oncology?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.